Ignite Creation Date:
2024-05-06 @ 7:35 PM
Last Modification Date:
2024-10-26 @ 3:10 PM
Study NCT ID:
NCT06068881
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-03
First Post:
2023-09-29
Brief Title:
A Study to Assess Efficacy and Safety of Oral Tazemetostat in Adult Participants With RelapsedRefractory Follicular Lymphoma That Does Not Have an EZH2 Gain-of-function Genetic Mutation
Sponsor:
Epizyme Inc
Organization:
Ipsen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-09-02
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-09-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-09-28
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-29
First Submit QC Date:
September 29 2023
Study First Post Date:
2023-10-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-31
Last Update Post Date:
2024-06-03
Last Update Post Date Type:
ACTUAL